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Gram-scale fermentative 
production of ergothioneine driven 
by overproduction of cysteine in 
Escherichia coli
Naoyuki tanaka1, Yusuke Kawano  1, Yasuharu satoh  2, tohru Dairi  2 & Iwao ohtsu1
ergothioneine (eRG), a unique thiol compound, is suggested to function as an antioxidant and 
cytoprotectant. Despite several recent attempts to produce eRG using various organisms, its yield 
was still very low and the costs remained high. since the level of eRG produced depends strictly on 
the availability of three distinct precursor amino acids (l-cysteine (Cys), l-histidine, and l-methionine 
(Met)), metabolic engineering for enhancement of the flux toward ERG biosynthesis is required. 
Herein, we took advantage of a high-Cys production system using Escherichia coli cells, in which Cys 
biosynthesis and excretion were activated, and applied it to the fermentative production of eRG 
from glucose. the Cys overproduction in E. coli cells carrying the egtBCDE genes from Mycobacterium 
smegmatis was effective for ERG production. Furthermore, coexpression of the egtA gene, which 
encodes γ-glutamylcysteine synthetase that synthesizes the γ-glutamylcysteine used as a sulfur source 
of eRG biosynthesis, enhanced eRG production even though E. coli intrinsically has γ-glutamylcysteine 
synthetase. Additionally, disruption of the metJ gene that encodes the transcriptional repressor 
involved in Met metabolism was effective in further increasing the production of ERG. Finally, we 
succeeded in the high-level production of 1.31 g/L ERG in a fed-batch culture process using a jar 
fermenter.
To all living organisms, l-cysteine (Cys) is an essential amino acid that contributes to a number of biological 
processes, including oxidative stress tolerance and protein folding, assembly, and stability through disulfide-bond 
formation1. Cys is also used as a sulfur donor for the biosynthesis of important biological sulfur-containing mol-
ecules, such as glutathione, thiamine, and biotin2,3. Most microbes and plants can synthesize Cys from environ-
mental inorganic sulfur sources. On the other hand, animals cannot assimilate inorganic sulfur sources, and 
instead obtain sulfur in the organic form as Cys and l-methionine (Met) through food intake. This implies that 
animals are completely dependent on bacterial and plant sulfur metabolites for their sulfur intake. In terms of 
this, organic sulfur-containing amino acids, including Cys, are industrially important. Bacterial fermentation is 
widely adopted for the mass production of many kinds of amino acids because of the benefits of industrial safety 
and cost effectiveness. In around 2000, the industrial-scale fermentative production of Cys was established by 
Wacker Chemie4. This fermentative approach, using Escherichia coli, is accomplished by the metabolic modifica-
tion of some Cys biosynthetic enzymes (Supplementary Fig. S1); however, the sulfur utilization by this bacterium 
is poorly understood. Recently, we have demonstrated that E. coli prefers thiosulfate over sulfate for Cys biosyn-
thesis5,6. This is because thiosulfate is advantageous for saving the consumption of NADPH and ATP molecules 
to synthesize Cys. That is, the sulfate pathway consumes two molecules of ATP and four molecules of NADPH 
as a reducing power to produce Cys from sulfate, whereas the thiosulfate pathway spends only one molecule of 
NADPH from thiosulfate. These facts led us to consider the potential advantage of converting overproduced Cys 
into beneficial Cys-derived compounds.
Ergothioneine (ERG), which is a betaine of 2-thiol-l-histidine, was first discovered in the ergot fun-
gus Claviceps purpurea, and is suggested to be a unique sulfur-containing antioxidant, similar to glutathione, 
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mycothiol, and bacillithiol7. Currently, ERG is known to be synthesized by limited kinds of microorganisms, such 
as mycobacteria (the order Actinomycetales), non-yeast-like fungi, and cyanobacteria8–10. Early studies carried 
out with cell-free extracts of Neurospora crassa demonstrated the requirement of three amino acids (viz., Cys, 
l-histidine (His), and l-methionine (Met)) for ERG biosynthesis11,12. Recently, Seebeck cloned five genes (egtA, 
egtB, egtC, egtD, and egtE) from Mycobacterium smegmatis and characterized their protein products in vitro, 
γ-GC) synthetase, catalyzes the formation of γ-GC from Cys and l-glutamate. EgtD, an S-adenosylmethionine 
(SAM)-dependent methyltransferase, mobilizes the methyl group from the substrate SAM and donates it 
to the amino group of His for the formation of hercynine (HER)12–14. HER and γ-GC are then converted into 
γ-glutamyl-hercynylcysteine sulfoxide via the oxidase hercynine oxygenase (EgtB), which requires oxygen 
and iron for its enzymatic activity15,16. Subsequently, EgtC, a glutamine amidotransamidase, facilitates the 
hydrolysis of the N-terminus glutamic acid, producing hercynylcysteine sulfoxide17. Finally, EgtE, a pyridoxal 
5-phosphate-dependent beta-lyase, produces ERG, releasing pyruvate and NH313.
Despite the limited range of organisms able to produce ERG, this amino acid derivative is also found in 
humans and other animals. Humans obtain ERG from their diet and accumulate it in various cells and tis-
sues (e.g., kidney, liver, central nervous system, and red blood cells) at high concentrations (100 µM to 2 mM) 
through a highly specific ERG transporter, organic cation/carnitine transporter 1 (OCTN1)7. Several reports 
have proposed that ERG behaves as an antioxidant, scavenging hydroxyl radicals to prevent DNA damage and 
lipid peroxide formation18–20. The biodegradation of many sulfur compounds, including Cys, often results in the 
generation of hydrogen sulfide, which has an unpleasant odor21,22. On the other hand, ERG is not easily biode-
graded, resulting in less unpleasant odors (our unpublished data). These unique properties of ERG are valuable 
for its use in a wide range of applications in the pharmaceutical, cosmetic, and food industries. Intact mushrooms 
(e.g., Pleurotus ostreatus) and cyanobacteria (e.g., Spirulina) have attracted attention as safe and accessible ERG 
sources7,23. However, their ERG contents are very low, at 0.4–2.0 mg/g dry weight in mushrooms and 0.8 mg/g 
dry weight in cyanobacteria24,25. In this respect, we recently showed that the high and heterologous expression of 
ERG enzymes of M. smegmatis in E. coli cells succeeded in producing 24 mg/L (104 µM) ERG in the broth super-
natant26. The overproduction system in Schizosaccharomyces pombe, whose ERG biosynthetic pathway is differ-
ent from that of M. smegmatis, resulted in an intracellular ERG yield of 370 mg/L (1.6 mM)27. However, further 
genetic and metabolic engineering studies are required to enhance the production of ERG.
In this study, using ERG biosynthetic genes from M. smegmatis, we applied a high-Cys-producing system to 
high ERG production and indeed showed its efficacy. We also propose that the biosynthetic activation of Met is 
key to the high-level production of ERG. Several further experiments to improve the biosynthetic flux of ERG 
succeeded in achieving its gram-scale production.
Results and Discussion
ERG production by a synthetic biological approach in E. coli and its enhancement by reinforcement of the sulfur 
metabolic flux toward γ-GC. In this study, we planned to establish a genetically engineered E. coli strain capable 
of high-level ERG production by a synthetic biological approach, since E. coli does not have ERG biosynthetic 
genes. Previously, we constructed three compatible plasmids into which each of egt genes (egtB, egtC, egtD, egtE) 
derived from M. smegmatis was cloned, and introduced them into E. coli strain to overproduce ERG enzymes in 
the cells26. These heterologous expressions allowed E. coli to biosynthesize ERG from inherently existing precur-
sor metabolites, His, SAM, and γ-GC (Fig. 1), resulting in 24 mg/L ERG. In order to further improve the pro-
ducing system for ERG, we here constructed the plasmid pQE1a-egtBCDE, capable of facilitating the isopropyl 
β-D-1-thiogalactopyranoside (IPTG)-inducible polycistronic expression of the egtBCDE derived from M. smeg-
matis in E. coli. The plasmid was introduced into the wild-type (WT) E. coli K-12 BW25113 strain to give WT 
pQE1a-egtBCDE. For the sake of facilitating later comparison with another genetic engineering construction (CH 
pQE1a-egtBCDE, mentioned below), a negative-control plasmid (pACYC184)28 was also introduced. We then 
examined whether this strain could produce extracellular ERG (Fig. 2). As a result, WT pQE1a pACYC184 did 
not produce ERG at all, whereas WT pQE1a-egtBCDE pACYC184 successfully produced 10 mg/L of ERG after 
120 h of cultivation, indicating the successful genetic design and construction for ERG production based on the 
heterologous expression of egtBCDE from M. smegmatis.
To further increase the ERG yield, we focused next on reinforcing the sulfur metabolic flux toward ERG 
biosynthesis, because this pathway was indicated to be the rate-limiting pathway in our previous study26. First, 
we attempted genetic engineering for a more effective biosynthesis of Cys. Previously, we introduced the plasmid 
pDES into the E. coli cells and found a remarkable production of Cys5,6,29. The plasmid pDES contains three genes 
from E. coli, the altered cysE gene encoding the Cys feedback inhibition-insensitive mutant SAT (T167A)30, the 
wild-type ydeD gene encoding inner membrane Cys exporter, and the altered serA gene encoding the l-serine 
feedback inhibition-insensitive mutant of d-3-phosphoglycerate dehydrogenase (T410stop). Expression of each 
gene is controlled by the constitutive promoter of the E. coli ompA gene encoding outer membrane protein A 
precursor. To adapt this high-Cys producing system for the purpose of ERG production, we redesigned and con-
structed plasmid pCysHP based on the pDES. WT pCysHP could produce a large amount of Cys (Supplementary 
Fig. S2), and we designated this strain as “CH” (Cys hyperproducer). Remarkably, CH pQE1a-egtBCDE produced 
40 mg/L of ERG after 120 h of cultivation, which was a 4-fold higher yield than that from WT pQE1a-egtBCDE 
pACYC184 (Fig. 2). This showed that the reinforcement of Cys biosynthesis is extremely effective for ERG pro-
duction. In order to test the effect of lack of ydeD gene on ERG production, we constructed the plasmid carrying 
the altered cysE gene and the altered serA gene by excision of the ydeD gene from the pCysHP, and then introduced 
it into the WT cells. No significant effect was observed on ERG production even though the amount of Cys 
decreased (data not shown). This result suggests that Cys production level without YdeD was adequate for pro-
duction of ERG under our conditions at present. After this, we employed the pCysHP in all experiments because 
of the higher Cys production.
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We subsequently attempted to enhance the Cys-to-γ-GC step. To this end, we constructed another plasmid, 
pQE1a-egtABCDE, capable of coexpressing the egtA gene of M. smegmatis. In this ERG biosynthesis, the γ-GC 
biosynthetic step is catalyzed by exogenous EgtA and endogenous glutamate-cysteine ligase (GshA) in E. coli. 
Notably, CH pQE1a-egtABCDE could produce 75 mg/L of ERG after 120 h of cultivation (Fig. 2), which was a 
2-fold higher yield than that from CH pQE1a-egtBCDE. This result indicated that EgtA coexpression contributed 
to enhancement of the γ-GC supply and subsequently higher ERG production.
γ-GC can be utilized in both biosynthetic pathways for glutathione and ERG. In E. coli, glutathione synthetase 
(GshB) is responsible for the catalytic synthesis of glutathione from γ-GC and glycine31,32. To facilitate the γ-GC 
supply toward ERG biosynthesis, we examined the effect of deletion of the GshB-encoding gene on ERG yield. 
Unexpectedly, no effect was seen on ERG production in the ΔgshB strain compared with the WT under our 
experimental conditions (Supplementary Fig. S3). It should be noted that the ERG produced could not com-
plement the slow growth phenotype of ΔgshB caused by the lack of glutathione33. Glutathione is known to play 
major roles in the intracellular antioxidative system in eukaryotes and some bacteria, including E. coli3. Because 
thiol compounds generally function as a reducing agent, ERG also plays a role such as Cys and glutathione. 
Although, there is no evidence for certain in vivo function of ERG. Several critical in vitro studies have demon-
strated unique properties of ERG that are different from those of any other thiol compounds: (i) at normal phys-
iological pH, ERG exists predominantly in the thione form rather than the thiol form7; (ii) ERG demonstrates 
a greater deactivation effect on singlet oxygen and hydroxyl radicals than other thiols, including glutathione18; 
and (iii) ERG has poor activity against hydrogen peroxide and superoxide18,19. These properties and our results 
indicate the different roles of ERG and glutathione (and other thiols) in vivo. Hydrogen peroxide and superoxide 
are scavenged by antioxidative enzymes, such as catalase and dismutase, as well as antioxidative thiols. However, 
cells do not have endogenous enzymes and compounds that can eliminate hydroxyl radicals and singlet oxygen 
directly. ERG might therefore play a role as the direct and sole scavenger of hydroxyl radicals.
Figure 1. Biosynthetic pathway of ERG in M. smegmatis. ERG biosynthesis is mediated by five enzymatic steps. 
Expression of the foreign genes for EgtB, EgtC, EgtD and EgtE allows E. coli cells to synthesize ERG. EgtA from 
M. smegmatis is not indispensable because E. coli possesses GshA that catalyzes formation of γ-GC from Cys 
and glutamate. Met is used following formation of SAM by SAM synthetase (MetK in E. coli).
www.nature.com/scientificreports/
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Effect of metJ gene disruption on ERG production. HER is synthesized from His and SAM by EgtD, 
which is a SAM-dependent methyltransferase (Fig. 1). SAM synthetase is the enzyme that catalyzes the conver-
sion of Met and ATP into SAM. Since the synthesis of one HER molecule requires one His molecule and three 
Met molecules, it is very likely that the biosynthetic steps of Met and SAM are rate-limiting in ERG produc-
tion. The transcriptional levels of various genes encoding enzymes in the Met and SAM biosynthetic pathways 
are controlled by the transcriptional repressor MetJ34. This repressor also represses the gene encoding MetR, 
which is a transcriptional activator responsible for several Met biosynthetic genes. We therefore focused on MetJ 
and assessed the impact of metJ gene disruption on the ERG productivity of the mutant strain. The pCysHP and 
pQE1a-egtABCDE plasmids were introduced into ΔmetJ cells (termed CH ΔmetJ pQE1a-egtABCDE), and the 
ERG productivity of the strain was evaluated. The ΔmetJ cells occurred in growth defect in the fermentative 
conditions (Fig. 3A). By contrast, CH ΔmetJ pQE1a-egtABCDE produced a higher amount of ERG (98 mg/L 
at 120 h) than CH pQE1a-egtABCDE did. These results indicated that metJ disruption is effective in improving 
the ERG yield, probably due to improvement of the biosynthetic steps toward Met and subsequently SAM and 
HER. In fact, when pCF1s-egtD, which allows the cells to synthesize HER26, was introduced into WT and ΔmetJ 
cells, HER production was higher in the ΔmetJ cells than in the WT (Fig. 3B). According to the EcoCyc data-
base (https://ecocyc.org/), MetJ regulates the transcriptional expression of 15 genes (Table 1). Of these, metF 
(encoding methylenetetrahydrofolate reductase, involved in Met biosynthesis) and metK (the SAM synthetase 
gene)35 are known to exhibit higher transcriptional levels in ΔmetJ than in the WT36. Thus, in our case of ERG 
Figure 2. Expression of pCysHP and egtA is remarkable efficient in ERG productivity. WT and CH harboring 
each of plasmids (pQE1a, pQE1a-egtBCDE, pQE1a-egtABCDE) were cultured in SM1 liquid medium. After 
6 h cultivation, IPTG and Na2S2O3 were added at concentrations of 0.1 mM and 10 mM respectively. Data are 
presented as mean values with standard errors from three independent experiments. pACYC184 as negative 
control for pCysHP was introduced into WT.
www.nature.com/scientificreports/
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Figure 3. Impact of metJ gene disruption on ERG and HER productivities. (A) CH pQE1a-egtABCDE and CH 
ΔmetJ pQE1a-egtABCDE were cultured in SM1 liquid medium. After 6 h cultivation, IPTG and Na2S2O3 were 
added at concentrations of 0.1 mM and 10 mM respectively. Cell density (left) was estimated from the OD at 
562 nm. ERG (right) in the cultured supernatant at 120 h was quantified by Sulfur index analysis described in 
Methods. (B) WT and ΔmetJ cells harboring pCysHP and pCF1s-egtD were cultured in SM1 liquid medium. 
After 6 h cultivation, IPTG and Na2S2O3 were added at concentrations of 0.1 mM and 10 mM respectively. HER 
in the cultured supernatant at 120 h was quantified by LC-MS/MS analysis. Data are presented as mean values 
with standard errors from three independent experiments.
Gene Function
metA Homoserine O-succinyltransferase,
metB O-succinylhomoserine(thiol)-lyase/O-succinylhomoserine lyase
metC cystathionine-β-lyase/Cys desulfhydrase
metE cobalamin-independent homocysteine transmethylase
metF 5,10-methylenetetrahydrofolate reductase
metI L-methionine/D-methionine ABC transporter membrane subunit
metK methionine adenosyltransferase
metL fused aspartate kinase/homoserine dehydrogenase 2
metN L-methionine/D-methionine ABC transporter ATP binding subunit
metR DNA-binding transcriptional regulator involved in methionine biosynthesis
metQ L-methionine/D-methionine ABC transporter membrane anchored binding protein
ahpC alkyl hydroperoxide reductase, AhpC component
ahpF alkyl hydroperoxide reductase, AhpF component
folE GTP cyclohydrolase 1
yeiB DUF418 domain-containing protein YeiB
Table 1. Genes regulated by transcriptional repressor MetJ in E. coli.
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production, such higher transcription levels and resulting activation of MetF and MetK in ΔmetJ are considered 
to be a trigger in facilitating HER production and consequently ERG production.
optimization of the fermentative conditions for eRG production. As His is the precursor of HER, 
we examined the effect of supplementation of His into the fermentation medium on ERG production. As shown 
in Fig. 4A, the supplementation of His enhanced ERG production significantly, resulting in 240 mg/L ERG at 
the His concentration of 5 mM. We therefore supplemented His at concentration 5 mM into the growth medium 
in following flask-scale experiments. In order to increase the amount of HER, we also examined the effect of 
an increase of Met concentration in the medium. The addition of Met only had no effect on ERG production 
(Fig. 4B). We speculated insufficient supply of His to accept methyl groups derived from Met for the enhance-
ment of HER production. Predictably, the combined addition of Met and His had an additive effect on the ERG 
productivity (275 mg/L) of the cells (Fig. 4B). These results suggest the significance and effectiveness of exceeding 
the supply of the precursors to overproduce ERG, but at the same time, implying the requirement of the further 
improvement of metabolic engineering to supply His and Met.
To facilitate the ERG productivity of E. coli further, we examined the effects of adding several supplements 
(e.g., minerals, amino acids, vitamins) into the fermentation medium and found that the supplementation of 
iron, in particular ammonium ferric citrate (AFC), had a significant effect on the stable production of ERG. In the 
presence of up to 5 mg/L AFC, ERG production increased in a concentration-dependent manner (Supplementary 
Fig. S4). This iron effect on ERG production is consistent with a previous report using Methylobacterium species27. 
In ERG biosynthesis, EgtB is dependent on iron for its catalysis16. Thus, a high ferric concentration might activate 
the enzymatic reaction mediated by EgtB. These observations suggest the potential for further refinement of the 
biosynthetic step by EgtB for ERG overproduction.
eRG production in a fed-batch culture. To attempt further enhancement of the ERG yield, we applied 
a jar fermenter to accomplish a higher cell density and thus effective ERG production, using the fed-batch tech-
nique with supply of glucose and precursors of ERG biosynthesis, respectively. The composition of the culture 
medium was based on the conditions investigated in the flask experiments above, but some components were 
prepared at somewhat higher concentrations (see Methods), taking into consideration the aim for a higher cell 
density in this culture system. Since EgtE contains a pyridoxal 5-phosphate as a cofactor13, enough pyridoxine (a 
precursor of pyridoxal 5-phosphate) was added to the growth medium in this experiment. In brief, the design of 
the culture process was based on the following ideas: at 0–24 h, no substrate was fed, with emphasis on a favora-
ble onset of cell growth; at 24–48 h, only glucose was fed, with emphasis on achieving the highest cell density 
possible beforehand; at 48 h, IPTG, additional AFC, and pyridoxine were added to initiate ERG production; and 
at 48–120 h, glucose and precursors of ERG biosynthesis (Met, His, and thiosulfate) were constantly fed, with 
emphasis on persistent and effective ERG production. In this experiment, CH ΔmetJ pQE1a-egtABCDE, the best 
ERG producer in the flask experiments mentioned above, was employed. Consequently, the cells grew well, with 
the OD660 reaching ~40 in 72 h and finally ~55 (Fig. 5A). ERG production in the supernatant increased from 120 h 
and reached 1,311 mg/L at 216 h (Fig. 5B). ERG production in the cells increased from 72 h, reached 261 mg/L at 
96 h, and decreased gradually thereafter (Fig. 5B). HER also accumulated in the supernatant in an almost similar 
time course to that of ERG production, but importantly, its concentration was much less than that of ERG (~1/20) 
at 216 h (Fig. 5C). Additionally, γ-GC accumulated in the cells mainly in the earlier period (24–72 h), but its level 
decreased in the period of ERG production (96 h onward) and the resulting level was likewise much less than 
that of ERG at 216 h (Fig. 5D). This decrease of γ-GC indicates that pre-accumulated γ-GC was appropriately 
Figure 4. Effect of supplementation with His and Met on ERG productivity. (A) CH ΔmetJ pQE1a-egtABCDE 
cells were cultured in SM1 liquid medium. After 6 h cultivation, His was added at various concentrations 
(0, 2.5, 5, 10 mM) together with IPTG, Na2S2O3 at concentrations of 0.1 mM and 10 mM respectively. ERG 
in the cultured supernatant at 120 h was quantified by Sulfur index analysis described in Methods. (B) CH 
ΔmetJ pQE1a-egtABCDE cells were cultured in SM1 liquid medium. After 6 h cultivation, His, Met, or their 
combination was added at concentrations of 5 mM and 3 mM, respectively, together with IPTG, Na2S2O3 at 
concentrations of 0.1 mM and 10 mM respectively. ERG in the cultured supernatant at 120 h was quantified by 
Sulfur index analysis described in Methods.
www.nature.com/scientificreports/
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consumed for the induction of ERG production. Additionally, γ-glutamyl-hercynylcysteine sulfoxide and her-
cynylcysteine sulfoxide, which are intermediates between HER and ERG (Fig. 1), were hardly detectable during 
the culture, both in the cell and supernatant (data not shown). These results suggest that there were no critical 
rate-limiting steps in the ERG biosynthetic metabolic flow in this strain. Taken together, both our genetic con-
struction and culture design were considered to have worked well. Notably, most of the ERG produced actually 
existed extracellularly (>93%) at 216 h. This trait should be preferable for purification of the ERG produced, 
which is necessary for practical ERG manufacturing in an industrial process, which is the goal of this study.
Interestingly, ERG production in the supernatant was slightly delayed compared with that in the cells, corre-
sponding to the induction of pQE1a-egtABCDE by IPTG addition at 48 h. It is possible that such delay and subse-
quent acceleration of extracellular ERG production might have involved an unknown ERG-exporting transporter. 
It should be noted that such ERG transporter is to our best knowledge currently unidentified in all biological 
species, although Mycobacterium species is reported to actively export ERG extracellularly37. Because E. coli itself 
does not have known ERG biosynthetic genes, and in fact does not produce ERG, such export might occur via a 
transporter for other structurally similar molecules, perhaps in a low specific manner. The exploration and iden-
tification of such ERG exporter gene and its application to appropriate genetic engineering would be a significant 
and promising approach to further accelerate and/or enhance the ERG productivity of bacterial cells.
Conclusions
Unlike Cys and glutathione, ERG does not release a sulfur odor, and is a biologically important thiol against 
hydroxyl radicals7,18,19. Its dietary intake is likely to reduce hydroxyl and other radicals safely and circumvent 
DNA damage and fatty acid peroxidation products, thereby inhibiting carcinogenesis, lifestyle-related chronic 
diseases, and aging7. Although an inexpensive and safe fermentation technique for ERG production using 
microbes is desired, Cys biosynthesis and its metabolic flux toward ERG biosynthesis (the rate-limiting steps 
in ERG biosynthesis) have hampered the hyperproduction of ERG. Recently, our technique for Cys fermenta-
tive production has reached the level of practical application (>16 g/L, our unpublished data), although further 
improvement is still needed for cost-effectiveness. This led us to the idea of applying Cys overproduction to 
an ERG-hyperproducing system. The present study has demonstrated that the synthetic biological approach of 
facilitating the heterologous expression of ERG biosynthetic genes from M. smegmatis in E. coli cells is practical 
Figure 5. ERG production in a fed-batch culture. Growth (A), ERG production (B), HER production (C), and 
γ-GC production (D) of CH ΔmetJ pQE1a-egtABCDE cells in the fed-batch culture by a jar fermenter. Growth 
was monitored by measuring OD660 of the culture cell suspension. ERG, HER, and γ-GC were measured by 
Sulfur index and the LC-MS/MS analysis described in Methods. For the measurements of “cell”, its metabolites 
were extracted beforehand, and utilized for measurements (described in Methods). For concentrations of 
indicated compounds in cell were calculated considering cell density in the culture at each time point. Data are 
presented as mean values with standard errors from three independent experiments.
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and viable, allowing the synthesis of ERG from the precursors His, SAM, and γ-GC. In addition, reinforcement 
of the γ-GC supply, by both genetic modification of the Cys biosynthetic pathway and additional expression of 
EgtA, was shown to be effective in increasing the ERG productivity of the cells. Similarly, reinforcement of the 
SAM supply by disruption of the transcriptional repressor MetJ was most effective as well. Importantly, we have, 
for the first time, successfully produced ERG on the gram scale (1.31 g/L) using the fed-batch culture technique. 
We believe that the present study will be a milestone by providing a practical approach to overproduce ERG in 
the industrial setting.
Methods
Bacterial strains and cell growth. The E. coli strains used in this study are listed in Table 238. LB medium 
was used as the standard medium. For fermentative production, the cells were grown in SM1 minimal medium 
(1 g/L Trypton, 0.5 g/L Yeast extract, 100 µM potassium phosphate buffer (pH 7.0), 75.7 µM (NH4)2SO4, 1.7 µM 
NaCl, 1.0 µM MgSO4, 0.1 µM CaCl2, 20 mg/L ammonium ferric citrate (AFC), 0.6 µM Na2MoO4, 40.4 µM H3BO3, 
2.9 µM CoCl2, 1 µM CuSO4, 8.1 µM MnCl2, 3.04 mM Met) supplemented with 3% glucose. When required, ampi-
cillin (Ap), tetracycline (Tc), kanamycin (Km) and streptomycin (Sm) were added at concentrations of 50, 10, 50 
and 50 µg/ml, respectively. Cultures were incubated aerobically by shaking at 30 °C. Growth was monitored by 
measurement of the optical density at 562 nm or 660 nm using U-1100 Spectrophotometer (HITACHI).
plasmid construction. Plasmids used in this study are listed in Table  3. Gene cluster includ-
ing egtBCDE genes (MSMEG_6246 to 6249) was amplified by PCR using genomic DNA of M. smeg-
matis ,  primers (5 ′-GGAGATATACATATGATCGCACGCGAGACACTGGCCGACGAG-3 ′  and 
5′-TATAAGCTTCAGGGCGCCTCACGCAACGCTG-3′), and Tks Gflex DNA polymerase (Takara Bio. Inc., 
Shiga, Japan). The amplified DNA fragment was digested with NdeI and HindIII, and then inserted into the cor-
responding sites of pQE1a-Red to obtain pQE1a-egtBCDE. To express egtABCDE gene cluster (MSMEG_6246 
to 6250), pQE1a-egtBCDE was modified. A DNA fragment including egtA was amplified by PCR using genomic 
DNA of M. smegmatis, primers (5′-GGAGATATACATATGGCCTTACCCGCCAGAAGTGATTCTG-3′ and 
5′-CGTGCTGTAGCGCTCGTAGATCATC-3′), Tks Gflex DNA polymerase. The fragment obtained was digested 
NdeI and AfeI and inserted into the corresponding sites of pQE1a-egtBCDE to obtain pQE1a-egtABCDE.
Fermentative production in flask scale. E. coli cells were grown in SM1 medium supplemented with a 
saturated amount of CaCO3 at 30 °C with shaking. At 6 h, Na2S2O3 and IPTG were added at 10 mM and 0.1 mM, 
respectively. To evaluate the growth, the cell suspension containing insoluble CaCO3 was added to 0.1 N HCl to 
dissolve CaCO3, after which the OD562 was measured. To determine the ERG concentration in the medium, the 
cell suspension was centrifuged, and the supernatant was appropriately diluted with H2O. For the reduction of 
ERG, the diluted supernatant was incubated in in 50 mM Tris-HCl buffer (pH 8.5) containing 5 mM dithiothreitol 
for 10 min at room temperature. The concentration of ERG was determined by Sulfur index analysis described 
below. For experiments of HER fermentative production, we used the E. coli strain harboring the plasmid 
pCF1s-egtD26 carrying egtD gene because of easy and sensitive detection of HER. HER levels were determined by 
LC-MS/MS analysis. Cys concentration was conducted by Gaitonde’s method as described39.
sulfur index analysis. The supernatants of cell culture were subjected to analysis of Sulfur index, which is 
defined as a profile of major sulfur metabolite contents, and measured by the sulfur metabolomic method6. Sulfur 
index is a sulfur-metabolomics by using combination of LC-MS/MS and thiol-specific derivatization method 
using monobromobimane. In this method, derivatized sulfur metabolites (e.g., Cys, γ-GC, and ERG) were reliably 
detected and quantified by the LC-MS/MS system. The target metabolite levels were determined from the peak 
Strain Genotype
Reference or 
source
BW25113 Wild type, rrnB3 ∆lacZ4787 hsdR514 ∆(araBAD)567 ∆(rhaBAD)568 rph-1
38
JW3909 BW25113 ∆metJ::Kmr 38
Table 2. E. coli strains used in this study.
Plasmid Description Reference or source
pACYC184 Cmr, Tcr, p15A replicon 28
pCysHP
Tcr, pACYC184 derivative carrying serA (T410 stop), ydeD and 
cysE (T167A, G203S, T234S, P252L, M256Q) from E. coli under 
the control of the ompA promoter
29, This study
pQE1a-Red Apr, ColE1 replicon, tac promoter 26
pQE1a-egtBCDE pQE1a-Red derivative carrying M. smegmatis egtBCDE This study
pQE1a-egtABCDE pQE1a-Red derivative carrying M. smegmatis egtABCDE This study
pCF1s-egtD Smr, pCF1s-Red derivative carrying M. smegmatis egtD 26
Table 3. Plasmids used in this study.
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area by mass chromatography, monitoring each m/z characteristic to the individual target, and were represented 
as relative amounts after normalization with the peak area of the internal standard (d-camphor-10-sulfonic acid).
eRG production in a fed-batch culture. E. coli cells were precultured overnight in LB medium at 30 °C 
using a baffled flask with rotary shaking. The cells were centrifugally collected, resuspended with 20 mL LB 
medium, and used as the inoculum. For the main culture performed in a 3-L jar fermenter (MBC-3; Sanki Seiki, 
Osaka, Japan), 1.1 L of the medium was prepared, which contained the following compounds; 23.24 g K2HPO4, 
9.06 g KH2PO4, 4 g tryptone, 2 g yeast extract, 1.2 g NaCl, 20 g (NH4)2SO4, 0.9 g Met, 60 mg AFC, 0.248 mg 
Na2MoO4, 5 mg H3BO3, 0.754 mg CoCl2, 0.32 mg CuSO4, 2.04 mg MnCl2, 240 mg MgSO4, 22.2 mg CaCl2, 40 g glu-
cose, and 3 mL Antifoam SI (Wako Pure Chemical Industries). After preparing pH of the medium (~6.8) to 6.9 by 
adding ammonia solution (28%) (Nacalai Tesque), the culture was started by adding the above-mentioned inoc-
ulum into the medium. The culture was performed at 30 °C, agitated at 490 rpm by two blade-type turbine impel-
lers, and aerated at 1 L/min. The pH of the culture medium was monitored and kept between 6.9–7.0 by automatic 
addition of ammonia solution (28%) (Nacalai Tesque) or 25% (v/v) H2SO4. From 24 to 48 h, 400 g/L glucose was 
constantly fed to the culture medium (58.3 µL per 12.6 sec; totally 400 ml). At 48 h, 2 mL of 10 g/L pyridoxine-HCl, 
1 mL of 30 g/L AFC, and 2 mL of 0.1 M IPTG were added. From 48 to 120 h, 400 g/L glucose was constantly fed 
(58.3 µL per 60.5 sec; totally 250 mL), and another mixed solution (18.2 g/L His-HCl monohydrate, 39.1 g/L Met, 
and 1.58 g/L Na2S2O3) was also fed constantly (58.3 µL per 60.5 sec; totally 250 mL). After completion of all the 
feedings mentioned, culture volume reached approximately 2 L. From 72 to 240 h, 1 ml of Antifoam SI was added 
every day. At the indicated time points, the cell suspension was sampled and its OD660 was measured to evaluate 
the growth after appropriate dilution with H2O. The supernatant samples were obtained after centrifugation of the 
suspension. The cell samples were obtained after centrifugation of the suspension and subsequent removal of its 
supernatant. The supernatant samples were appropriately diluted with H2O. The cell samples were resuspended 
with 80% (v/v) methanol and its metabolites including ERG were extracted from the cells by bath sonication 
treatments. After centrifugation, supernatant was obtained, dried up by centrifugal evaporator, resuspended with 
H2O water, centrifuged again, and its supernatant was utilized as the cell extract sample.
Data Availability
The datasets generated during the current study are available from the corresponding author on reasonable request.
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